NIPH Clinical Trials Search

UMIN ID: UMIN000001525

Registered date:01/01/2009

Relationship between compliance of Self-Monitoring of Blood Glucose (SMBG) and control of blood glucose

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedType 2 diabetes
Date of first enrollment2009/01/01
Target sample size400
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Blood sampling from flat of a hand drugs Blood sampling from a finger tip No operation of SMBG Treatment by only oral anti-diabetic drugs Treatment by insulin


Primary Outcome1) Level of HbA1c reduction 2) Number of times of SMBG (Compliance)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. Type 1 DM or secondary diabetes 2. Patients who performed SMBG in 1 year 3. Improvement by 0.5% or more in HbA1c in 3 months 4. Patients who have depression, psychiatric diseases and alcoholism 5. Patients who have malignant cancers 6. Patients who have abnormal hemoglobin 7. Patients who are not permitted to participate in this trial by attending doctors

Related Information


public contact
Address Japan
Telephone 075-751-3560
Affiliation Graduate Shcool of Medicine, Kyoto University Department of Diabetes and Clinical Nutrition
scientific contact
Name INAGAKI, nobuya
Address Syogoin Kawahara-cho 54, Sakyo-ku, Kyoto-city, Kyoto, Japan Japan
Affiliation Graduate School of Medicine, Kyoto University Department of Diabetes and Clinical Nutrition